American Century Companies’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
RI
DC
TCM
American Century Companies's CGON Position: Q2 2026 in Review
American Century Companies increased its CG Oncology (CGON) stake by 14,698% in Q2 2026, buying an estimated $47.1M and bringing the position to 726,154 shares worth $51.6M. The position accounts for 0.02% of the portfolio, ranked #844.
American Century Companies first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.
- American Century Companies held 726,154 shares of CG Oncology worth $51.6M as of Q2 2026.
- American Century Companies bought 721,247 CG Oncology shares in Q2 2026, an estimated $47.1M.
- CG Oncology made up 0.02% of American Century Companies's portfolio in Q2 2026, its #844 holding.
- American Century Companies first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
- 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.